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# Recommendation Lead Agency Progress to end-2020
1
The Department of Health will ensure that policies under the Healthy 
Ireland framework are implemented in full and that opportunities to 
address cancer prevention measures under those policies are maximised. 
In particular, measures aimed at further reducing smoking levels will be 
pursued.
DOH
The NCCP has provided input into the HSE's Tobacco Cessation Support Programme and continues to be centrally involved in the smoking 
cessation effort. 
In November 2020, a provision of the Public Health (Alcohol) Act which addresses the separation and display of alcohol products in mixed 
trade retailers, and the advertising associated with those products, came into effect. 
Following work through 2020, further regulations to restrict price-based promotions of alcohol were signed by the Minister for Health and 
came into effect 11 January 2021. The purpose of the regulations is to ensure that alcohol products cannot be sold cheaply, or given free of 
charge, as part of a price promotion or as part of loyalty card schemes.
Further provisions relating to alcohol advertising in sport will be considered in 2021, as will legislation to ban the sale of e-cigarette and 
vaping products to those under 18 years of age.
2
The National Cancer Control Programme (NCCP) will develop a cancer 
prevention function, working in conjunction with the broader Healthy 
Ireland  initiative, and will lead in relation to the development and 
implementation of policies and programmes focused on cancer 
prevention. 
NCCP
The NCCP cancer prevention function continues to participate in, and actively supports, Healthy Ireland and HSE public health programmes. 
The Irish Cancer Prevention Network, comprising the NCCP, Irish Cancer Society, Marie Keating Foundation and Breakthrough Cancer 
Research was expanded in 2020 to include the Irish Skin Foundation. The network facilitates collaboration on cancer prevention initiatives, 
the agreement of consistent evidence-based cancer prevention public awareness messages and support of national programmes. 
The network delivered a stakeholder webinar in 2020 on cancer prevention and published the Irish Cancer Prevention Network infographic 
on evidence-based cancer prevention messages. The network continues to provide education sessions and awareness initiatives to health 
care professionals and to the public on cancer prevention. The Network has developed a HPV lesson plan for inclusion in the junior cycle 
curriculum.
3
The Department of Health will develop a national skin cancer prevention 
plan and oversee its implementation as a priority. It will prioritise 
children, outdoor workers, sunbed users and those who pursue outdoor 
leisure activities.
DOH
A National Skin Cancer Prevention Plan was launched in 2019. Meetings of the Prevention Plan's Implementation Group continued in 2020, 
with the early focus on children and outdoor workers. 
Progress in 2020 included UV information being included in Met Éireann messaging; a greater focus on shade in the Universal Design 
Guidelines for Early Learning and Care settings; and support for SunSmart campaigns by national charitable organisations through evidence 
review and material promotion.
Funding from the Sláintecare initiative facilitated the recruitment, in December 2020, of a Cancer Prevention Officer to co-ordinate 
implementation of the Plan.
4
The NCCP will develop a systematic, evidence-based mechanism to 
ascertain the potential benefits and the cost-effectiveness of various 
initiatives (including chemoprevention) which will inform future cancer 
prevention programmes.
NCCP
The NCCP, in conjunction with the Irish Cancer Prevention Network, is continuing to monitor new emerging evidence, international 
initiatives and developments in cancer prevention. Planning is underway in relation to a more formalised process of assessment.
5
The HSE will ensure that the appropriate endoscopy capacity is provided 
in hospitals to allow for the expansion of BowelScreen to all aged 55-74 by 
end-2021.
HSE
This Recommendation is reflected in the HSE's National Service Plan for 2021 which commits to developing a capacity plan that meets the 
current endoscopy demand for the screening population, as well as developing a plan, in collaboration with the Department, to facilitate 
the roll-out of sufficient capacity to support the extension of the BowelScreen programme over time.
In 2020, approximately 1,800  patients were  referred for further treatment or surveillance from the BowelScreen Programme (a reduction 
on the previous year, due to the Covid pandemic). The immediate focus will be on the recovery of BowelScreen to pre-Covid levels before 
the expansion to all aged 55-74 (currently 60-69) is considered further.
6
The NCCP will draw up a plan by end-2017 for the development of an 
integrated cancer control and surveillance service for defined population 
subgroups with an inherited familial predisposition to cancer (e.g. breast, 
ovarian and colorectal).
NCCP
The NCCP previously undertook a stakeholder survey, through the designated cancer centres, as part of their assessment of the level of 
genetic testing infrastructure. 
In 2020, the results of the survey were used to inform work on a Hereditary Cancer Model of Care, covering the identification and 
assessment of those with possible hereditary cancer risk, referral for counselling and testing when indicated, and coordinated surveillance 
when required. While progress on the Model of Care has been delayed by Covid-19, the NCCP is looking at an Advanced Nurse Practitioner 
led model for the management and follow-up of those with a known risk of an inherited familial predisposition to cancer.
7
The NCCP and the HSE Health & Wellbeing Directorate, in partnership with 
the voluntary sector, will develop a rolling programme of targeted multi-
media based public awareness and education campaigns, aimed at the 
early detection of specific cancers and with particular focus on at-risk 
populations. 
NCCP
The NCCP, in conjunction with the Irish Cancer Prevention Network, is continuing to assess the progress being achieved on international 
prevention initiatives and to monitor evidence regarding the efficacy of potential new cancer public awareness programmes. 
A National Lung Cancer awareness campaign, developed in conjunction with voluntary sector organisations was due to be launched in April 
2020, but was delayed due to Coivd-19. However, the NCCP collaborated with the voluntary sector to conduct lung cancer public awareness 
campaigns in September and November 2020 and continues to work with community organisations to develop and promote cancer 
awareness in local communities.
8
The NCCP, working with the ICGP and the National Clinical Effectiveness 
Committee, will develop a three year plan to enhance the care pathways 
between primary and secondary care for specific cancers. The plan will set 
out criteria for referral to diagnostics and incorporate the requirements 
for additional Rapid Access Clinics.
NCCP
The updated GP Guidelines for Referrals to the Symptomatic Breast Disease Clinics were finalised in Q4 2020 and will be implemented in 
2021.
In 2020, the NCCP continued to monitor the referrals of cancers that fall outside existing Rapid Access Clinics, including through the pilot 
Rapid Access Haematuria Clinic in Roscommon University Hospital. Engagement with the Irish Council of General Practitioners and the 
National Clinical Effectiveness Committee is ongoing. 
9
The NCCP will ensure that cancer referrals from a GP into a hospital will be 
made electronically. Each Hospital Group will facilitate the phasing in of e-
referral.  This will be completed by the end of 2022.
NCCP
A total of 52,343 electronic cancer referrals were received in 2020 (a 13% increase on 2019). A Pilot project for the Pigmented Lesion 
Electronic Cancer Referral Form commenced in Cork in September 2019 and continued through 2020.
10
The Department of Health will liaise with the Health and Education 
authorities with a view to increasing places in Third Level Institutions for 
the training of radiographers and sonographers.
DOH
In 2018, the number of places on the undergraduate degree programme on radiography provided by UCD was increased from approximately 
45 to 100 per year, in line with increasing demand. This will start to impact on availability of radiographers from mid- 2022.
11
The NCCP, working with the other Directorates in the HSE, will develop 
criteria by end-2018 for the referral of patients with suspected cancer, 
who fall outside of existing Rapid Access Clinics, for diagnostic tests. The 
NCCP will ensure, through these criteria, that GPs will have direct access 
to cancer diagnostics within agreed timelines.
NCCP
The Early Cancer Diagnosis Steering Group continued its work through 2020. The Steering Group facilitated the publication of a new GP 
Colorectal Referral Pathway which is currently being implemented and it has commenced consideration of approaches for improving access 
to gynaecological cancer services.
The improvements made for GP access to diagnostics, generally, in the context of Covid-19 and Winter Plan, have impacted positively on 
cancer patients. The NCCP continues to work with the Radiology Programme to develop direct access to radiology diagnostics nationally.  
Direct access to MRI, CT, X-Ray and DEXA scans is available to GPs in each of the nine Community Health Organisations nationally for GMS 
patients.
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12
The NCCP will further develop the model of care for cancer to achieve 
integration between primary care and hospital settings at all stages of the 
cancer continuum, from diagnosis to post treatment care.
NCCP
The National Cancer Survivorship Needs Assessment was published in 2019. The Needs Assessment outlines key areas in which integration 
between primary care, the community sector, and hospital settings can be improved. The NCCP is worked to progress issues arising from the 
Needs Assessment in 2020 and has ongoing GP support for the integration effort.
The Model of Care for Psycho-Oncology was approved in September 2020. This will help to increase the awareness of all supports available 
to ensure patients and their families can access services when needed. Also, Best Practice Guidance for Community Cancer Support Centres 
and Services  was launched and disseminated in 2020.
Proposals on the Systemic Anti-Cancer Therapy (SACT) Model of Care were nearing completion at end 2020 and these will range across 
hospital, primary care and home settings. 
13
Patients diagnosed with cancer will have their case formally discussed at a 
multi-disciplinary team meeting.  The NCCP, working with the Hospital 
Groups, will oversee and support MDT composition, processes and 
reporting of outcomes.
NCCP
All common tumours are discussed at MDT meetings.  The rollout of the National Cancer Information System (NCIS) will allow for the 
collection of MDT information on an ongoing basis. 
Standard Operating Procedures (SOPs) for colorectal cancer was signed-off in 2020. SOPs for haematology, melanoma and breast cancer are 
already in place. 
14
The NCCP, working with the other Directorates in the HSE and with the 
Department of Health, will develop a rolling capital investment plan, to be 
reviewed annually, with the aim of ensuring that cancer facilities meet 
requirements.
NCCP
Capital funding under the National Development Plan 2018-2027 will facilitate the development of cancer facilities in line with the National 
Cancer Strategy. The plan includes the continued development of Radiation Oncology to meet patient demand, expansion and 
improvement of medical oncology units and day wards, improvements in diagnostic facilities and investment in aseptic compounding 
infrastructure, as well as the development of a comprehensive cancer care centre.
In 2020, video bronchoscopes were replaced in all cancer centres.  Also, a business case for an equipment replacement programme over a 
number of years in the St. Luke's Radiation Oncology Network, covering Beaumont, St James's and St Lukes Hospitals in Dublin, was 
approved.
As part of a Brexit-related initiative, funding was provided to increase resilience in chemotherapy compounding in acute hospitals and so 
reduce Ireland's reliance on outsourced compounding from UK manufacturers.  17 additional staff were recruited in 2020, with a further 10 
posts to be recruited in early 2021.  
15
The Department of Health will ensure that investment in infrastructure, 
facilities, personnel and programmes in the designated cancer centres will 
have a goal of ultimately developing at least one comprehensive cancer 
care centre that will optimise cancer prevention, treatment, education 
and research during the Strategy period.
DOH
The development of a comprehensive cancer care centre has always been seen as a matter for the latter part of the Strategy period. It is 
included in the National Development Plan 2018-2027. In 2020, the Department and the NCCP commenced consideration of the steps 
required towards the implementation of this recommendation.
16
The NCCP will ensure that consultant appointments for radiology, 
endoscopy and histopathology, where necessary, are made in conjunction 
with appointments in other disciplines such as surgery and medical 
oncology.
NCCP
Following a review of Rapid Access Clinics, additional Radiology and Pathology support has been allocated to each designated cancer centre. 
The positions associated with this have been approved and are at various stages of recruitment.
17
The NCCP will appoint a National Lead for Cancer Molecular Diagnostics 
for solid and liquid malignancies.
NCCP
Work was on-going at end 2020 in the HSE to progress the recruitment of a National Lead in Genomics. 
When the National Lead in Genomics is in place, the NCCP will be in a position to better define the role of a National Lead for Cancer 
Molecular Diagnostics for solid and liquid malignancies and then to pursue the appointment.
18
The NCCP will establish a Steering Group for Cancer Molecular 
Diagnostics, chaired by the National Lead. This Steering Group will set out 
the framework for the organisation, location and delivery of cancer 
molecular diagnostic services.
NCCP
The Steering Group will be established following the appointment of a National Lead for Cancer Molecular Diagnostics (Recommendation 
17).
19
The NCCP will further develop the Programme for Hereditary Cancers to 
ensure that evaluation, counselling, testing and risk reduction 
interventions are available as appropriate, and that services are available 
to patients on the basis of need.
NCCP
A Model of Care for Hereditary Cancer is being developed (Recommendation 6).  Increased staffing was previously provided to the 
Hereditary Cancer service in St. James's Hospital, including a Consultant in Cancer Genetics who took up post in 2020, to support this 
service. In November 2020, St. James's commenced a trial of a remote genetics testing provider, with the aim of improving turnaround 
times for testing during the Covid-19 period. 
20
The HSE will ensure that the existing cancer genetics services are 
amalgamated into one National Cancer Genetics Service and will identify 
the most appropriate site for its location.
HSE
The NCCP has completed scoping of cancer genetics services in all designated cancer centres (Recommendation 6). The identification of a 
site for a National Cancer Genetics Service has been impacted by Covid-19 and will be progressed as soon as practicable. 
21
The NCCP will draw up a plan setting out the number/location of 
designated cancer centres in which surgery will take place for the various 
tumour types.  Timescales for the implementation of the plan will be 
included for each tumour type.
NCCP
Some progress was made in 2020 on the implementation of the further centralisation of cancer surgery, particularly in relation to colorectal 
(South/Southwest Hospital Group) and gynaecological cancers (Saolta Hospital Group), despite the Covid-19 pandemic.  In light of the 
impact of the pandemic on theatres, ICU and HDU capacity, much public time-sensitive cancer surgery was undertaken in private hospitals 
in 2020. 
22
In line with the National Plan for Radiation Oncology, public sector 
radiation oncology facilities in Dublin, Cork and Galway will be expanded 
to meet patient demand and a planned National Programme of 
Equipment Refreshment and Replacement will be implemented across the 
Strategy period.
NCCP
Full transition to the new radiation oncology facility in Cork University Hospital was completed in Q4 2020. 
Enabling works were completed for the radiation oncology facility in University Hospital Galway and the main construction commenced in 
August 2020. 
Design work was progressed for the planned expanded radiation oncology facilities in Beaumont Hospital. 
23
The NCCP will examine the model of care for patients receiving oral anti-
cancer medicines and recommend steps to ensure that all patients receive 
such medicines in a safe and effective manner, with appropriate and 
proportionate supports, both in the hospital and community setting.
NCCP
An Implementation Group is working to ensure implementation of the Model of Care for Oral Anti-Cancer Medications.  An Oral Anti-Cancer 
Medicine training programme has been developed by the Irish Institute of Pharmacy (IIOP) and has been made available to pharmacists 
since July 2020.
24
The NCCP will develop appropriate MDT, centralisation and treatment 
arrangements to meet the diverse needs of patients with haematological 
cancers.
NCCP
The standard protocol for haematology multi-disciplinary teams in hospitals has been agreed. A Haemato-Oncology Expert Advisory Group is 
in place and a Project Lead has been assigned. 
Initial data gathering has taken place to support the objective of better meeting the diverse needs of haematological cancer patients. 
Progress in 2020 was delayed due to Covid-19.
25
The NCCP will develop a systematic, evidence-based mechanism to 
prioritise the establishment of MDTs for further rare cancers. The 
centralisation of diagnosis, treatment planning and surgical services for 
these cancers will be organised in line with best international practice.
NCCP
National chemotherapy regimens have been developed for drugs for a number of rare cancers.
Quality indicators are being used to assess MDT functioning. Standard Operating Procedures (SOPs) have been developed for Colorectal 
MDTs.
Research work is being progressed for the development of a systemic evidence-based approach for further rare cancers. 
Funding was provided to Beaumont hospital for the development of a national service for penile cancers in 2020.
26
The HSE will ensure that an age appropriate facility is designated for 
adolescents and young adults with cancer within the new children’s 
hospital.
HSE
The new Children's Hospital will provide age-appropriate facilities and will increase inpatient cancer capacity by 50%. 
Adolescent and Young Adult beds will increase from 2 to 6. The facilities will feature a den for Adolescent and Young Adult patients, which is 
aimed at meeting some of the particular needs of this age group. 
27
The HSE will develop closer links, on a hub and spoke model, between the 
National Centre for Child and Adolescent Cancer and the other designated 
cancer centres to provide appropriate and flexible transition 
arrangements for adolescents/young adults. This will include the joint 
appointment of adolescent/young adult oncologists and haemato-
oncologists and the provision of age-appropriate psycho-social support for 
these patients.   
HSE
The NCCP Clinical Lead for Children Adolescents and Young Adults (CAYA) was appointed in 2019. Since then, a scoping exercise of current 
CAYA cancer services has been completed, which included a site visit to Glasgow Teenage Young Adult (TYA) services. 
The NCCP CAYA Cancer Clinical Leads Group was set up in April 2019 to oversee and implement the recommendations of the National 
Cancer Strategy and enhance the practice and delivery of CAYA with cancer nationally. 
An NCCP CAYA Assistant Director of Nursing was appointed in Q4 2020 and a CAYA Consultant for Crumlin/SJH is currently being recruited.
28
Links between cancer services and geriatric services will be strengthened, 
facilitated by the appointment of a National Clinical Lead in Geriatric 
Oncology in the NCCP.
NCCP
The NCCP has appointed a Geriatric Advanced Nurse Practitioner (ANP) to support the specialised geriatric oncology service at Waterford 
University Hospital. The National Clinical Lead in Geriatric Oncology was not progressed in 2020 due to pressures arising from the Covid-19 
pandemic. 
29
The NCCP will appoint a National Clinical Lead for Psycho-oncology to 
drive the delivery of networked services.
NCCP A National Clinical Lead for Psycho-Oncology is in place.  A Psycho-Oncology Advisory Group was established in 2020.
30
Each designated cancer centre will establish a dedicated service to 
address the psycho-social needs of patients with cancer and their families. 
This will operate through a hub and spoke model, utilising the MDT 
approach, to provide equitable patient access.
NCCP
The Model of Care for Psycho-Oncology was approved in September 2020 and implementation is underway.  Six psycho-oncology MDT posts 
are in place and recruitment of the remaining two is underway.
Best Practice Guidance for Community Cancer Support Centres & Services  was published in August 2020 and has been disseminated to 
centres & services nationally. A self-assessment for community cancer support centres commenced on a pilot basis. T he NCCP also published 
guidance on the safe operation of Cancer Support Centres in the context of Covid-19 in August 2020 and supported this with a webinar for 
centres.
In response to Covid-19, a virtual psycho-oncology service (Together 4 Cancer Concern) was established in April 2020 by the NCCP in 
conjunction with Cancer Care West and the Irish Cancer Society. This service provided psychological support for cancer patients and their 
families through the pandemic.
31
Designated cancer centres will have a sufficient complement of specialist 
palliative care professionals, including psycho-oncologists, to meet the 
needs of patients and families (such services will be developed on a 
phased basis to be available over seven days a week).
NCCP
During 2020, the NCCP liaised with the National Clinical Programme for Palliative Care (clinical lead, nurse lead and programme manager) 
with a view to ensuring that the National Cancer Strategy objectives, cancer service developments and the HSE palliative care programme 
are aligned. This work has a particular focus on the provision of appropriate psycho-oncology support to meet the needs of patients and 
families.
32
Oncology staff will have the training and education to ensure competence 
in the identification, assessment and management of patients with 
palliative care needs and all patients with cancer will have regular, 
standardised assessment of their needs.
HSE
Implementation of the Palliative Model of Care is being progressed and the NCCP is linking in with this work. In consultation with the 
Palliative Care Programme, the NCCP is working on the development of two Advanced Nurse Practitioner posts in Palliative Care. 
33
The HSE will oversee the further development of children’s palliative care 
to ensure that services are available to all children with a life limiting 
cancer.
HSE
A sub-group of the Steering Group for Children, Adolescents and Young Adults is assessing children's palliative care services, in conjunction 
with the Clinical Lead for Children, Adolescents and Young Adults.
The use of a handheld treatment summary record started in June 2020 in Children's Health Ireland (CHI) and was rolled out to all patients by 
the end of the year.
34
The NCCP will ensure that each hospital has a clearly defined framework 
for cancer patient safety and quality.
NCCP
A national framework on cancer patient safety and quality is in place. The National Cancer Quality Steering Committee oversaw the 
implementation of a pilot project at St James's Hospital Lung Cancer Service in 2020 and this has been evaluated.  A second pilot project is 
being planned.
35
The NCCP will define focused cancer patient experience surveys to 
incorporate treatment and survivorship in line with HIQA's standard 
approach for the National In-Patient Acute Care Patient Experience 
Survey.
NCCP
The National In-Patient Acute Care Patient Experience Survey is conducted in May each year in a partnership involving HIQA, the HSE and 
the Department of Health. Cancer treatment and survivorship was selected as priority areas for inclusion in the National Care Experience 
Programme for 2021. However, due to Covid-19, the programme has been delayed and it is now likely that the survey on cancer patient 
experience will be progressed in 2022.
36
The NCCP will develop, publish and monitor a programme of national 
quality healthcare indicators for cancer care, involving both process and 
outcome measures, in line with international standards.
NCCP
The Quality Indicators Working Group (Department of Health, NCCP and NCRI) has undertaken a national review of available data  and is 
considering the optimum national quality health indicators for cancer care in Ireland. The NCCP, in 2020, reviewed international quality 
healthcare indicators for cancer, including the work of the Innovative Partnership for Action Against Cancer (iPAAC) EU Joint Action. This 
work will inform the development of national quality health indicators in Ireland.
37
The NCCP will develop further guidelines for cancer care in line with 
National Clinical Effectiveness Committee (NCEC) Standards.  Audits will 
also be developed in accordance with the NCEC Framework for National 
Clinical Audit.
NCCP
Colon and Rectal Clinical Guidelines were approved by the NCEC in November 2020. Guidelines have now been published for 8 cancer 
tumour types.
National Clinical Guidelines for Prostate Cancer and Gestational Trophoblastic Disease were updated in July 2020 and the update of the 
Breast Cancer National Clinical Guideline for Radiation Oncology commenced in November 2020. 
Throughout 2020, in response to Covid-19, the NCCP rapidly developed, adapted and disseminated national guidelines on cancer care to 
support cancer services across systemic anti-cancer therapy delivery, radiation oncology, surgical oncology and diagnostic services. This 
work facilitated the continuation of cancer services through the pandemic.
38
The Department of Health will ensure that patient representatives are 
involved in policy making, planning, practice and oversight of cancer 
services at local, regional and national levels.
DOH
The Department of Health strives to ensure that patient representatives are included in the oversight of the development and 
implementation of all cancer policies and services, particularly through the Cancer Patient Advisory Committee. At a local level, Patient 
Advisory Liaison Services (not limited to cancer) have been established to offer support, advice and information on hospital services to 
patients, family members, the general public and hospital staff.
Patients participate on the NCCP’s Community Oncology, Survivorship and Psycho-Oncology Working Groups, with wider consultation and 
collaboration with patient groups and advocacy organisations taking place on an on-going basis. In 2020 patients engaged directly with the 
NCCP cancer prevention network to develop videos sharing their own stories and encouraging patients with symptoms of cancer to attend 
their GP during the Covid-19 pandemic.  An NCCP Forum which aims to match patients/patient representatives with appropriate groups and 
projects within the NCCP has also been established.
39
The Department of Health will establish a Cancer Patient Advisory 
Committee to provide input into the development of programmes for 
patients with cancer. Membership of this committee will reflect the 
diverse nature of patients living with the effects of cancer, and will ensure 
that the needs of patients living in more remote areas are represented.
DOH
The Cancer Patient Advisory Committee met regularly during 2020. Issues considered by the Committee include the impact of Covid-19 on 
cancer patients, an acute oncology project in Cork University Hospital which aims to reduce the number of oncology patients admitted 
through the Emergency Department, the hereditary cancer nurse-led service in St James's Hospital and the new Europe's Beating Cancer 
Plan. 
Efforts are being made to introduce topics to the Committee at an earlier stage in their development so that members can more readily 
impact on improving the patient experience.
40
All hospitals will offer patients a Patient Treatment Summary and Care 
Plan as part of their support. These plans will allow patients to store 
information about their cancer, their cancer treatment and their follow-up 
care. The plans will also inform future healthcare providers.
NCCP
Work on a Minimum Data Set for Treatment Summary was progressed in 2020 in consultation with designated cancer centres. This process 
will support the development of Patient Treatment Summary and Care Plans for specific tumour sites.
A Colorectal Patient Passport is in pilot phase in 7 hospitals. Evaluations at patient level and service level is planned at 6 months and 12 
months, after which any changes to the passport design will be made before national rollout. Consideration will then be given to 
commencing the patient passport for other tumour sites. 
41
The NCCP, in conjunction with the ICGP, cancer centres, the Irish Cancer 
Society and cancer support centres, will conduct a Cancer Survivorship 
Needs Assessment to ascertain the most suitable model of survivorship 
healthcare. The Needs Assessment should be completed by the end of 
2018.
NCCP
The National Cancer Survivorship Needs Assessment (August 2019) was used in 2020, to inform the development and implementation of 
policy and services to meet patient needs. The needs assessment includes a model of care for Cancer Survivorship.
42
The NCCP, in conjunction with the cancer centres, will develop shared 
care protocols for patients with cancer following treatment. These 
protocols will span the hospital and primary care settings.
NCCP
The issues pertaining to patients following treatment are being considered by the NCCP's Survivorship Working Group. During 2020, the 
Group progressed work on the standardisation of follow-up/surveillance protocols to inform the development of Patient Treatment 
Summary and Care Plans. 
The Colorectal Cancer Leads Group drafted a plan to facilitate the roll-out of pilot projects for the follow-up and surveillance of colorectal 
cancer patients as soon as this is considered appropriate in light of the Covid-19 pandemic.
The NCCP is working to scope the possibility of using a similar approach for breast, prostate, lung and gynaecological cancers.
43
Designated cancer centres working with the NCCP, the ICGP, primary care 
services, patients and voluntary organisations will develop and implement 
survivorship programmes. These programmes will emphasise physical, 
psychological and social factors that affect health and wellbeing, while 
being adaptable to patients with specific survivorship needs following 
their treatment.
NCCP
The Cancer Thriving & Surviving Programme is being implemented across acute and community settings. Leader training sessions continue in 
various locations to facilitate expansion of the programme nationally. 
The NCCP is collaborating with the Irish Cancer Society to establish peer-supported End of Treatment Survivorship Workshops (LACES - Life 
After Cancer Enhancing Survivorship) in designated cancer centres. The workshops will be run virtually due to the impact of Covid-19. 
Filming and content has been completed and a pilot will be launched in Q2 2021.
Pilot Women’s Cancer Survivorship Clinics were established at Cork University Hospital and the Mater Hospital in 2020 as part of the 
Women’s Health Initiative which aims to improve health and wellbeing for women cancer survivors at all stages of their journey.
44
The central role of the NCCP in ensuring that the National Cancer Strategy 
2017-2026 is implemented across the health service will be strengthened, 
including through the use of Service Level Agreements, and through a 
direct role in financial allocations to Hospital Groups under Activity Based 
Funding.
NCCP
The NCCP continued to work proactively to advance cancer services across the HSE, and with hospitals and community services, throughout 
the Covid-19 pandemic. An important part of this work was the rapid reviews of clinical guidelines, carried out in conjunction with clinicians. 
The NCCP is continuing their central role in the HSE in ensuring the implementation of the National Cancer Strategy, with funding being 
utilised in a targeted way to maximise improvements in the quality and accessibility of cancer services.
45
The NCCP will work with the private sector providers to achieve voluntary 
participation in cancer data collection, audit, compliance with guidelines 
and reporting of outcomes.
NCCP
It is envisaged that cancer data from private sector providers will be more accessible when legislation covering the licensing of hospitals is 
enacted. The Government approved the text of the Patient Safety Bill in December 2019. The Bill has passed the First and Second Stage and 
will next progress to Dáil Committee Stage.
46
The NCCP will establish a National Cancer Research Group by end-2017 to 
improve the coordination of cancer research, to foster a supportive 
environment for research within the health service and the universities, to 
set research priorities in line with the overall cancer strategy, to seek to 
ensure that funding allocation is linked to these priorities and to work to 
achieve continuity of funding.
NCCP
The National Cancer Research Group is in place and includes representatives of the Department, NCCP, Health Research Board and Irish 
Cancer Society. Progress in 2020 was limited due to the focus on the response to the Covid-19 pandemic.
47
The HSE will ensure that clinical cancer research, and the staff who deliver 
it, become a fully integrated component of cancer care delivery.
HSE
The NCCP continues to work with the central research function in the HSE to promote an increased focus on research and is endeavouring to 
ensure the inclusion of time for the pursuit of research interests in contracts for Consultants and Advanced Nurse Practitioners. 
The NCCP supported the development of nursing/allied health professional research through the Cancer Nursing Research Award 
2019/2020. 
The NCCP survivorship programme collaborates with the Irish Cancer Society in regard to the latter's  research grant calls, with a view to 
supporting on-going work on cancer survivorship.
48
The NCCP and the National Cancer Research Group will examine 
mechanisms to ensure that newly appointed cancer consultants and 
Advanced Nurse Practitioners have protected time to pursue research 
interests in their new posts.
NCCP
Time for the pursuit of research interests has been included in the job specifications of many consultants and Advanced Nurse Practitioners. 
The NCCP has interacted directly with some of the newly hired Advanced Nurse Practitioners in 2020 to consider how best to incorporate 
research into their work.
However, with the focus on the continuation of cancer services during the Covid-19 pandemic in 2020, protected time for research was 
necessarily limited.
49
The NCCP will appoint a National Clinical Lead for Cancer Nursing. This 
person will work with other Directorates in the HSE and with the 
Department of Health to determine an integrated nursing leadership 
infrastructure for cancer nursing services at national, regional and local 
levels to support practice and research.
NCCP
A National Clinical Lead for Cancer Nursing is in place.  In 2020, her role included working with stakeholders in relation to nursing research, 
dealing with the appointment of 26 acute oncology nurses to avoid cancer patients being admitted through Emergency Departments, and 
linking with the Irish Cancer Society in relation to Daffodil Centre Nurses working directly to support acute oncology services in hospitals in 
the early stages of the Covid-19 pandemic. 
The Clinical Lead has also progressed work on a workforce development plan, unscheduled care initiatives and a Community Oncology 
Nursing Programme Cost Comparison Study. 
50
The NCCP, aided by a cross-sector group, will draw up a comprehensive 
workforce plan for cancer services. This will include an interim assessment 
of staffing needs at medical, nursing and health & social care professional 
levels by mid-2018.
NCCP
Current workforce, the supply of skilled personnel, and projected future demands are all subject to continual assessment and revision. 
Developments in clinical guidelines, pathways, practices and technologies, existing and projected skills supply, the timing of commencement 
of new initiatives, and external factors serve to influence the profile of resource requirements. The NCCP works closely with a range of 
bodies in planning the cancer services workforce. 
In 2020, the NCCP commenced a workforce planning exercise for cancer nursing, led by the National Clinical Lead. Significant research was 
also undertaken with regard to workforce planning, international standards & best practice for Medical oncology. A workforce plan for 
Radiation Oncology has been in operation since 2017.
51
The HSE will ensure that all hospitals provide the National Cancer Registry 
with data related to cancer in an appropriate timeframe to allow for 
sufficient surveillance of cancer rates and outcomes in Ireland.
HSE
A Data-Sharing Agreement between the HSE and the National Cancer Registry is in place covering all public hospitals. Individual data-sharing 
agreements with many voluntary and private hospitals are also in place, and work was progressing at end-2020 to finalise the outstanding 
cases. 
2020 saw significant advances in electronic data transfer. From mid-2020 the NCRI has been collecting data remotely from all public 
hospitals. This has facilitated the continued collection of data during the Covid-19 pandemic and has increased the completeness and 
timeliness of NCRI data.
52
The Department of Health will review the scope of the National Cancer 
Registry with a view to increasing and optimising the use of available data 
to drive improvements in cancer care for patients.
DOH
The National Cancer Registry Strategic Plan 2020-2022, launched in September 2020 sets out the high-level goals of the NCRI over the next 3 
years. The Plan facilitates an enhanced contribution to the development of cancer policy by the NCRI and will enable the NCRI to more 
effectively address its core functions, while expanding the cancer patient data it collects.
The Strategic Plan focuses on increasing and optimising the uses of available data to drive improvements in cancer care for patients. The 
Plan supports the delivery of the recommendations of the Report of the Scoping Inquiry into the CervicalCheck Screening Programme , as 
they pertain to the NCRI.
